N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 1.721 NOK 1.24% Market Closed
Market Cap: 562m NOK

Wall Street
Price Targets

NYKD Price Targets Summary
Nykode Therapeutics ASA

Wall Street analysts forecast NYKD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NYKD is 5.202 NOK with a low forecast of 1.818 NOK and a high forecast of 8.925 NOK.

Lowest
Price Target
1.818 NOK
6% Upside
Average
Price Target
5.202 NOK
202% Upside
Highest
Price Target
8.925 NOK
419% Upside
Nykode Therapeutics ASA Competitors:
Price Targets
688382
InventisBio Co Ltd
6% Downside
688428
InnoCare Pharma Ltd
17% Downside
688278
Xiamen Amoytop Biotech Co Ltd
14% Upside
2162
KeyMed Biosciences Inc
14% Downside
ARGX
argenx SE
27% Upside
YMAB
Y-mAbs Therapeutics Inc
72% Upside
XGN
Exagen Inc
20% Upside
TRDA
Entrada Therapeutics Inc
297% Upside

Revenue
Forecast

Revenue Estimate
Nykode Therapeutics ASA

For the last 7 years the compound annual growth rate for Nykode Therapeutics ASA's revenue is 110%.

110%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Nykode Therapeutics ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NYKD's stock price target?
Price Target
5.202 NOK

According to Wall Street analysts, the average 1-year price target for NYKD is 5.202 NOK with a low forecast of 1.818 NOK and a high forecast of 8.925 NOK.

Back to Top